Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 147.1	$ 141.8
Trade and other accounts receivable (less allowances of $7.7 million and $5.1 million, respectively)	334.6	284.5
Inventories (less allowances of $27.1 million and $25.4 million, respectively):
Finished goods	259.3	188.3
Raw materials	113.8	89.3
Total inventories	373.1	277.6
Prepaid expenses	14.1	18.0
Prepaid income taxes	3.3	5.8
Other current assets	0.4	0.4
Total current assets	872.6	728.1
Net property, plant and equipment	220.9	214.4
Operating leases right-of-use assets	45.3	35.4
Goodwill	358.8	364.3
Other intangible assets	45.0	57.5
Deferred tax assets	5.9	6.4
Pension asset	48.1	159.8
Other non-current assets	7.1	5.0
Total assets	1,603.7	1,570.9
Current liabilities:
Accounts payable	165.3	148.7
Accrued liabilities	202.9	166.5
Current portion of finance leases	0.0	0.1
Current portion of operating lease liabilities	13.9	12.4
Current portion of plant closure provisions	5.3	5.2
Current portion of accrued income taxes	18.4	3.7
Total current liabilities	405.8	336.6
Operating lease liabilities, net of current portion	31.4	23.1
Plant closure provisions, net of current portion	51.9	51.3
Accrued income taxes, net of current portion	21.0	30.6
Unrecognized tax benefits, net of current portion	13.4	16.3
Deferred tax liabilities	26.2	60.8
Pension liabilities and post-employment benefits	12.2	17.8
Other non-current liabilities	1.4	1.4
Total liabilities	563.3	537.9
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	354.1	346.7
Treasury stock (4,788,966 and 4,780,806 shares at cost, respectively)	(95.4)	(90.6)
Retained earnings	924.2	822.9
Accumulated other comprehensive loss	(145.2)	(46.9)
Total Innospec stockholders' equity	1,038.0	1,032.4
Non-controlling interest	2.4	0.6
Total equity	1,040.4	1,033.0
Total liabilities and equity	$ 1,603.7	$ 1,570.9